As Annual Recurring Revenue Accelerates, CrowdStrike Buy?
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesCrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Trump says the conflict is complete, but Wall Street expects the Fed to stay hawkish. Oil spikes, inflation worries, ...
A colossal DeFi trade on AAVE's swap interface left a trader facing a near $50 million loss after a mispriced swap. R...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...
A contrarian take on the tech sell-off. Learn why durable AI and cloud trends could spark a rebound and how to positi...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Analysts issued fresh upgrades on a slate of big-name stocks as earnings season continues. Applied Materials, Devon E...
XRP faces a critical moment as it again tests the $1.50 resistance, with bulls hoping for a sustained breakout while ...
After a Q1 earnings miss, Coinbase investors are eyeing a bold growth thesis centered on subscription revenue, deriva...
Cisco shattered expectations with a record Q3 revenue print and elevated AI infrastructure guidance, triggering a cho...